Shedding light on the mutational landscape of the most common pediatric cancer
Thursday, September 22, 2016 - 08:02
in Health & Medicine
Genomic alterations have been discovered in pediatric relapsed ALL that cause both therapy resistance and improved clinical response to multi-agent chemotherapy treatment.